LOXL2 and neoplasm: To conclude, our experiments identify LOXL2 as a novel deacetylase that directly interacts and deacetylates aldolase A. This in turn induces its release from filamentous actin and enzymatic activity, leading to increased glycolysis which subsequently contributes to tumor development and tumor metastasis (Fig. 6I).